Immunologic cross-reaction between HIV type 1 p17 and Mycoplasma hyorhinis variable lipoprotein

AIDS Research and Human Retroviruses

Volumn 14, Issue 5, 1998, Pages 419-425

  Pincus, Seth H ^a,b   Cole, Robert L ^a   Watson Mckown, Robyn ^c   Pinter, Abraham ^d   Honnen, William ^d   Cole, Barry ^e   Wise, Kim S ^c   Smaus, Susan ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b MONTANA STATE UNIVERSITY   (United States)

^c University of Missouri   (United States)

^d PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY P17; PROTEIN P17; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CROSS REACTION; HUMAN IMMUNODEFICIENCY VIRUS 1; MYCOPLASMA; MYCOPLASMA HYORHINIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; STRAIN DIFFERENCE;

EID: 0032549554     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1998.14.419     Document Type: Article

References (31)

1. Pincus SH and Tolstikov VV: Anti-human immunodeficiency virus immunoconjugates. Adv Pharmacol 1995;32:205-242.
2. Tung JS, Yohsiki T, and Fleissner E: A core polyprotein of murine leukemia virus on the surface of mouse leukemia cells. Cell 1979;9:573-578.
3. Pincus SH, Cole R, Ireland R, McAtee F, Fujisawa R, and Portis J: Protective efficacy of non-neutralizing monoclonal antibodies in acute infection with murine leukemia virus. J Virol 1995;69: 7152-7158.
4. Shang F, Huang H, Revesz K, Chen H-C, Herz R, and Pinter A: Characterization of monoclonal antibodies against the HIV matrix protein p17: Identification of epitopes exposed at the surfaces of infected cells. J Virol 1991;65:4798-4804.
5. Laurent AG, Krust B, Rey M-A, Montagnier L, and Hovanessian AG: Cell surface expression of several species of HIV-1 major core protein. J Virol 1989;63:4074-4078.
6. Papsidero LD, Sheu M, and Ruscetti FW: HIV-1 neutralizing monoclonal antibodies that react with the p17 core protein: Characterization and epitope mapping. J Virol 1989;63:267-272.
7. McGarrity GJ, Kotani H, and Butler GH: Mycoplasmas and tissue culture cells: In: Mycoplasmas: Molecular Biology and Pathogenesis (Maniloff J, McElhaney RN, Finch LR, and Baseman JB, eds.) American Society of Microbiology, Washington, D.C., 1992, pp. 445-454.
8. Wise KS, Cassell GH, and Acton RT: Selective association of murine T lymphoblastoid cell surface alloantigens with Mycoplasma hyorhinis. Proc Natl Acad Sci USA 1978;75:4479-4483.
9. Cole BC, Naot Y, Stanbridge EJ, and Wise KS: Interactions of the mycoplasmas and their products with lymphoid cells in vitro. In: The Mycoplasmas, Vol. IV. Academic Press, San Diego, California, 1985, pp. 204-253.
10. McGarrity GJ, Murphy DG, and Nichols WW: Mycoplasma Infection of Cell Cultures. Plenum Press, New York, 1978, p. 342.
11. Lo SC, Hayes MM, Wang RY, Pierce PF, Kotani H, and Shih JW: Newly discovered mycoplasma isolated from patients infected with HIV. Lancet 1991;338:1415-1418.
12. Grau O, Slizewicz B, Tuppin P, Launay V, Bourgeois E, Sagot N, Moynier M, Lafeuillade A, Bachelz H, and Clauvel JP: Association of Mycoplasma penetrans with HIV infection. J Infect Dis 1995;172:672-681.
13. Blanchard A and Montagnier L: AIDS associated mycoplasmas. Annu Rev Microbiol 1994;48:687-712.
14. Sasaki Y, Blanchard A, Watson HL, Garcia S, Dulioust A, Montagnier L, and Gougeon ML: In vitro influence of Mycoplasma penetrans on activation of peripheral T lymphocytes from healthy donors or HIV-infected individuals. Infect Immun 1995;63:4277-4283.
15. Chowdhury MI, Munakata T, Koyanagi Y, Arai S, and Yamamoto N: Mycoplasma stimulates HIV-1 expression from acutely and dormantly-infected promonocyte/monoblastoid cell lines. Arch Virol 1994;139:431-438.
16. Lo SC, Tsai S, Benish JR, Shih JW, Wear DJ, and Wong DM: Enhancement of HIV-1 cytocidal effects in CD4+ lymphocytes by the AIDS-associated mycoplasma. Science 1991;251:1074-1076.
17. Vasudevachari MB, Mast TC, and Salzman NP: Suppression of HIV-1 reverse transcriptase activity of mycoplasma contamination of cell cultures. AIDS Res Hum Retroviruses 1990;6:411-416.
18. Pincus SH, and McClure J: Soluble CD4 enhances the efficacy of immunotoxins directed against gp41 of the human immunodeficiency virus. Proc Natl Acad Sci USA 1993;90:332-336.
19. Pincus SH, Wehrly K, Cole R, Fang H, Lewis GK, McClure J, Conley AJ, Wahren B, Posner MR, Notkins AL, Tilley SA, Pinter A, Eiden L, Teintze M, and Dorward D: In vitro effects of anti-HIV immunotoxins directed against multiple epitopes on the HIV-1 envelope glycoprotein gp160. AIDS Res Hum Retroviruses 1996;12:1041-1051.
20. Yogev D, Watson-McKown R, Rosengarten R, Im J, and Wise KS: Increased structural and combinatorial diversity in an extended family of genes encoding VIp surface proteins of Mycoplasma hyorhinis. Infect Immun 1995;177:5636-5643.
21. Pincus SH and Wehrly K: AZT demonstrates anti-HIV-1 activity in persistently infected cell lines: Implications for combination chemotherapy and immunotherapy. J Infect Dis 1990;162:1233-1238.
22. Pincus SH, Cole JAL, Hersh EM, Lake D, Masuho Y, Durda PJ, and McClure J: In vitro efficacy of anti-HIV immunotoxins targeted by various antibodies to the envelope protein. J Immunol 1991;146:4315-4324.
23. Pincus SH, Wehrly K, and Chesebro B: Use of a focal infectivity assay for testing susceptibility of HIV to antiviral agents. BioTechniques 1991;10:336-342.
24. Boyer MJ and Wise KS: Lipid modified surface protein antigens expressing size variation within the species Mycoplasma hyorhinis. Infect Immun 1989;57:245-254.
25. Rosengarten R and Wise KS: The Vlp system of Mycoplasma Avorhinis: Combinatorial expression of distinct size variant lipoproteins generating high-frequency surface antigenic variation. J Bacteriol 1991;173:4782-4793.
26. Yogev D, Rosengarten R, Watson-McKown R, and Wise KS: Molecular basis of Mycoplasma surface antigenic variation: A novel set of divergent genes undergo spontaneous mutation of periodic coding regions and 5′ regulatory sequences. EMBO J 1991;10: 4069-4079.
27. Corbin A, Prats AC, Darlix JL, and Sitbon M: A nonstructural gag-encoded glycoprotein precursor is necessary for efficient spreading and pathogenesis of murine leukemia viruses. J Virol 1994;68: 3857-3867.
28. Portis JL, Spangrude GJ, and McAtee FJ: Identification of a sequence in the unique 5′ open reading frame of the gene encoding glycosylated Gag which influences the incubation period of neurodegenerative disease induced by murine retrovirus. J Virol 1994;68:3879-3887.
29. Pinter A, Honnen WJ, Revesz K, and Herz R: Identification of large glycosylated proteins recognized by monoclonal antibodies against HIV-1 Gag proteins. AIDS Res Hum Retroviruses 1992;8:1341-1344.
30. Wise KS: Adaptive surface variation in mycoplasmas. Trends Microbiol 1993;1:59-63.
31. Theiss PM, Kim MF, and Wise KS: Differential protein expression and surface presentation generates high-frequency antigenic variation in Mycoplasma fermentans. Infect Immun 1993;61:5123-5128.